Risk Factors Associated with Failure of Linezolid Therapy in Vancomycin-Resistant Enterococcus faecium Bacteremia: A Retrospective Cohort Study in a Referral Center in Mexico

We aimed to assess the factors associated with 30-day mortality in patients with vancomycin-resistant Enterococcus faecium (VREf) bloodstream infection (BSI) who received treatment with linezolid in an 11-year retrospective cohort of patients with VREf BSI. A univariate and stepwise multivariate log...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Microbial drug resistance (Larchmont, N.Y.) N.Y.), 2022-06, Vol.28 (6), p.744-749
Hauptverfasser:	Lopez-Luis, Bruno Ali, Ponce-De-León, Alfredo, Ortiz-Brizuela, Edgar, Lambraño-Castillo, Darwin, Leal-Vega, Francisco Javier, Tovar-Calderón, Yanet Estrella, Bobadilla-Del-Valle, Miriam, Sifuentes-Osornio, José
Format:	Artikel
Sprache:	eng
Schlagworte:	Anti-Bacterial Agents - pharmacology Antibiotic resistance Antibiotics Bacteremia Bacteremia - drug therapy Cohort analysis Cohort Studies Confidence intervals Disease Enterococcus faecium Gram-Positive Bacterial Infections - drug therapy Hazards Humans Linezolid Linezolid - adverse effects Linezolid - therapeutic use Mexico Mortality Mortality factors Multivariate analysis Patients Referral and Consultation Regression analysis Retrospective Studies Risk analysis Risk Factors Statistical analysis Vancomycin Vancomycin - therapeutic use Vancomycin-Resistant Enterococci
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!